share_log

Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Decreases By 21.9%

Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Decreases By 21.9%

空头股数在ProShares UltraShort纳斯达克生物技术公司(纳斯达克:国际清算银行)的持股减少21.9%
Defense World ·  2022/07/06 03:01

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the recipient of a significant decline in short interest in the month of June. As of June 15th, there was short interest totalling 11,800 shares, a decline of 21.9% from the May 31st total of 15,100 shares. Based on an average daily trading volume, of 21,900 shares, the days-to-cover ratio is currently 0.5 days.

ProShares UltraShort纳斯达克生物科技公司(纳斯达克:BIS-GET评级)在6月份空头股数的销售额大幅下降。截至6月15日,空头股数共有11,800股,较5月31日的15,100股减少21.9%。以日均成交量21,900股计算,目前天数与回补比率为0.5天。

Shares of BIS opened at $24.68 on Wednesday. The stock's fifty day moving average price is $29.23 and its two-hundred day moving average price is $26.20. ProShares UltraShort Nasdaq Biotechnology has a 1 year low of $15.86 and a 1 year high of $35.64.

周三,国际清算银行的股价开盘报24.68美元。该股的50日移动均线价格为29.23美元,200日移动均线价格为26.20美元。ProShares UltraShort纳斯达克生物科技的一年低点为15.86美元,一年高位为35.64美元。

Get
到达
ProShares UltraShort Nasdaq Biotechnology
ProShares超短波纳斯达克生物技术
alerts:
警报:

Several institutional investors and hedge funds have recently modified their holdings of the business. IMC Chicago LLC bought a new stake in shares of ProShares UltraShort Nasdaq Biotechnology during the 1st quarter valued at $450,000. OLD Mission Capital LLC bought a new stake in shares of ProShares UltraShort Nasdaq Biotechnology during the 4th quarter valued at $266,000. Finally, UBS Group AG raised its stake in shares of ProShares UltraShort Nasdaq Biotechnology by 54.7% during the 1st quarter. UBS Group AG now owns 1,371 shares of the company's stock valued at $33,000 after purchasing an additional 485 shares during the period.

几家机构投资者和对冲基金最近调整了对该公司的持股。IMC芝加哥有限责任公司在第一季度购买了ProShares UltraShort纳斯达克生物科技公司的新股,价值45万美元。旧使命资本有限责任公司在第四季度购买了ProShares UltraShort纳斯达克生物科技公司的新股份,价值266,000美元。最后,瑞银集团在第一季度增持了ProShares UltraShort纳斯达克生物科技公司的股份54.7%。瑞银集团(UBS Group AG)在此期间又购买了485股,目前持有1,371股该公司股票,价值33,000美元。

About ProShares UltraShort Nasdaq Biotechnology
关于ProShares UltraShort纳斯达克生物技术
(Get Rating)
(获取评级)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.

ProShares超纳斯达克生物科技(基金)只寻求一天的投资结果,不寻求较长时期的投资结果。基金寻求扣除费用和费用前的每日投资结果,相当于该指数每日业绩的两倍(200%)。超过一个交易日的基金回报将是这段时间内每一天的回报的复合结果,这很可能与同期纳斯达克生物技术指数(该指数)的回报两倍(200%)不同。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
  • Get Defensive With These Three Upgrades
  • Looking to Dump These 3 Possible Delisted Chinese Stocks? Let's Take a Look.
  • 3 Home Improvement Stocks That Can Renovate Your Portfolio
  • Vera Bradley Stock Getting Cheap
  • 3 Education Stocks to Enroll in This Summer
  • 免费获取StockNews.com关于ProShares UltraShort纳斯达克生物技术的研究报告
  • 在这三个升级中保持防御
  • 想抛售这3只可能退市的中国股票吗?让我们来看看。
  • 3只家装类股,可以重塑你的投资组合
  • 维拉·布拉德利的股票越来越便宜
  • 3只教育类股将于今夏入围

Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.

获得ProShares UltraShort纳斯达克生物科技日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对ProShares UltraShort纳斯达克生物技术和相关公司的最新新闻和分析师评级的每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发